58.03

0.29% 0.18

Bio Techne Corp (TECH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario Storia dei dividendi

Precedente Chiudi:

$57.85

Aprire:

$56.89

Volume 24 ore:

351.75K

Relative Volume:

0.17

Capitalizzazione di mercato:

$9.08B

Reddito:

$1.22B

Utile/perdita netta:

$77.95M

Rapporto P/E:

118.62

EPS:

0.4892

Flusso di cassa netto:

$224.06M

1 W Prestazione:

+0.17%

1M Prestazione:

-11.90%

6M Prestazione:

+6.63%

1 anno Prestazione:

-6.72%

Intervallo 1D:

$56.25

$58.65

Intervallo di 1 settimana:

$54.59

$59.06

Portata 52W:

$46.01

$72.16

Bio Techne Corp Stock (TECH) Company Profile

Nome

Bio Techne Corp

Settore

Healthcare (1111)

Industria

Biotechnology (621)

Telefono

612-379-8854

Indirizzo

614 MCKINLEY PL N E, MINNEAPOLIS, MN

Dipendente

3,100

Cinguettio

@biotechne

Prossima data di guadagno

2024-10-30

Ultimi documenti SEC

TECH's Discussions on Twitter

Compare TECH vs VRTX, REGN, ARGX, ALNY, ONC

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TECH Bio Techne Corp	58.06	9.05B	1.22B	77.95M	224.06M	0.4892
VRTX Vertex Pharmaceuticals Inc	471.18	121.40B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	773.05	83.25B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	731.90	46.39B	4.16B	1.29B	734.26M	19.59
ALNY Alnylam Pharmaceuticals Inc	323.49	43.41B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	295.38	33.09B	5.36B	287.73M	924.18M	2.5229

Bio Techne Corp Stock (TECH) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-09-03	Aggiornamento	RBC Capital Mkts	Sector Perform → Outperform
2025-08-21	Aggiornamento	Citigroup	Neutral → Buy
2025-07-22	Ripresa	Stephens	Overweight
2025-07-09	Iniziato	TD Cowen	Buy
2025-05-30	Iniziato	Wells Fargo	Overweight
2025-04-09	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
2025-03-18	Iniziato	Evercore ISI	Outperform
2025-02-19	Downgrade	Robert W. Baird	Outperform → Neutral
2024-05-22	Downgrade	Citigroup	Buy → Neutral
2024-02-08	Iniziato	Scotiabank	Sector Outperform
2024-02-02	Downgrade	Stifel	Buy → Hold
2023-12-07	Iniziato	UBS	Buy
2023-08-28	Iniziato	William Blair	Outperform
2023-01-10	Aggiornamento	Wells Fargo	Underweight → Equal Weight
2022-12-14	Iniziato	Deutsche Bank	Buy
2022-12-12	Aggiornamento	Citigroup	Neutral → Buy
2022-12-07	Iniziato	RBC Capital Mkts	Sector Perform
2022-08-25	Iniziato	Credit Suisse	Outperform
2022-04-25	Downgrade	Wells Fargo	Equal Weight → Underweight
2021-09-15	Aggiornamento	KeyBanc Capital Markets	Sector Weight → Overweight
2021-03-08	Aggiornamento	Stephens	Equal-Weight → Overweight
2021-02-23	Aggiornamento	Stifel	Hold → Buy
2021-01-25	Reiterato	The Benchmark Company	Buy
2020-11-10	Iniziato	KeyBanc Capital Markets	Sector Weight
2020-09-30	Iniziato	Atlantic Equities	Overweight
2020-07-15	Downgrade	Stephens	Overweight → Equal-Weight
2020-05-27	Downgrade	Stifel	Buy → Hold
2020-05-14	Iniziato	The Benchmark Company	Buy
2020-01-08	Ripresa	Stephens	Overweight
2020-01-08	Iniziato	Wells Fargo	Equal Weight
2020-01-07	Iniziato	Citigroup	Neutral
2019-11-15	Iniziato	Stifel	Buy
2019-07-02	Aggiornamento	Janney	Neutral → Buy
2019-01-14	Aggiornamento	Stephens	Equal-Weight → Overweight
2018-10-31	Downgrade	Craig Hallum	Buy → Hold
2018-10-17	Iniziato	Goldman	Neutral
2018-06-15	Iniziato	Argus	Buy
2017-07-13	Iniziato	Wells Fargo	Market Perform
2017-02-09	Iniziato	Citigroup	Buy
2017-01-18	Iniziato	Deutsche Bank	Buy
2016-11-10	Ripresa	Leerink Partners	Outperform
2015-01-21	Reiterato	Robert W. Baird	Outperform
2013-09-20	Aggiornamento	Robert W. Baird	Neutral → Outperform

Mostra tutto

Bio Techne Corp Borsa (TECH) Ultime notizie

Mar 04, 2026

TECH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Mar 04, 2026

TD Asset Management Inc Acquires 36,424 Shares of Bio-Techne Corp $TECH - MarketBeat

Mar 04, 2026

Cresset Asset Management Boosts Stake in Bio-Techne - National Today

Mar 04, 2026

Cresset Asset Management LLC Increases Position in Bio-Techne Corp $TECH - MarketBeat

Mar 04, 2026

Mar 03, 2026

Bio-Techne Corp. stock outperforms competitors despite losses on the day - MarketWatch

Mar 03, 2026

Bio-Techne at TD Cowen Conference: Strategic Growth and Challenges - Investing.com

Mar 03, 2026

TECH Technical Analysis & ETF Price Forecast - Intellectia AI

Mar 03, 2026

Segall Bryant & Hamill LLC Sells 34,680 Shares of Bio-Techne Corp $TECH - MarketBeat

Mar 03, 2026

Champlain Investment Partners LLC Sells 963,441 Shares of Bio-Techne Corp $TECH - MarketBeat

Mar 03, 2026

American Century Companies Inc. Boosts Bio-Techne Stake - National Today

Mar 03, 2026

American Century Companies Inc. Grows Stock Position in Bio-Techne Corp $TECH - MarketBeat

Mar 03, 2026

3 Reasons to Avoid TECH and 1 Stock to Buy Instead - Finviz

Mar 03, 2026

Citigroup Trims Stake in Bio-Techne Corp - National Today

Mar 03, 2026

Mar 02, 2026

Bio-Techne Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Mar 02, 2026

Bio-Techne Corp. stock underperforms Monday when compared to competitors - MarketWatch

Mar 02, 2026

Royce & Associates Cuts Stake in Bio-Techne Corp - National Today

Mar 02, 2026